All News
Filter News
Found 2,543 articles
-
Moderna to Host Virtual Vaccines Day on April 14, 2020
4/7/2020
Moderna, Inc. announced that it will host its virtual Vaccines Day for analysts and investors at 8:00 a.m. ET on Tuesday, April 14.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 6, 2020.
-
When tested in mice, the vaccine, which is delivered through a fingertip-sized patch, produced the antibodies specific to the novel coronavirus that causes COVID-19.
-
Flagship began raising the funds in January, and closed on it late last week.
-
The funds will focus on early-stage biotech companies, with some possible co-investing from both funds.
-
Flagship Pioneering Completes Raising a New $1.1 Billion Capital Pool
4/2/2020
Flagship Pioneering, a unique life sciences innovation enterprise, announced that on March 27, it closed a $1.1 billion capital raise for its seventh Origination Fund to support the creation of Human Health and Sustainability companies originated and operating within its Flagship Labs unit.
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 31, 2020.
-
Cobra Biologics and the Karolinska Institutet, secured millions in emergency funding from Horizon 2020 to support research and development and an eventual Phase I clinical trial testing of a DNA vaccine against COVID-19.
-
Moderna Provides Update on the Impact of COVID-19 on Business Operations and Clinical Program Development
3/30/2020
Moderna, Inc. provided an update on the impact of the rapidly evolving COVID-19 pandemic on its business operations and clinical program development.
-
One of the key takeaways from BIO-Europe Spring 2020 was that there is a keen need for greater collaboration and communications among the biotech community, government, non-governmental organizations and the public.
-
Frequency Therapeutics Provides Business Updates and Reports Fourth Quarter and Full Year 2019 Financial Results
3/26/2020
Frequency Therapeutics, Inc. today announced business updates and financial results for the fourth quarter and year ended December 31, 2019.
-
Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund
3/25/2020
Repertoire Immune Medicines, a newly launched company working to unleash the curative power of the immune system to prevent and cure disease, today announced an investment from the JDRF T1D Fund, a venture philanthropy vehicle focused on accelerating life-changing solutions to cure, prevent and treat type 1 diabetes (T1D).
-
Moderna to Present at MIT Lecture Series
3/25/2020
Moderna, Inc., (Nasdaq: MRNA) today announced that Stéphane Bancel, Chief Executive Officer will participate in the MIT Laboratory for Financial Engineering (LFE) and Golub Center for Finance and Policy (GCFP) Distinguished Lecture Series, “Dealing with Coronavirus: An Industry Perspective” on Wednesday, April 1 from 4:30-6:00 p.m. EDT.
-
Gilead Suspends Access to Remdesivir Due to 'Overwhelming Demand' for the Experimental COVID-19 T...
3/23/2020
In order to continue to provide patients with access to the potential treatment, Gilead said it is in the process of transitioning from individual compassionate use requests to expanded access programs. -
Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis
3/23/2020
- In the months since the global public health crisis rose from a regional crisis to a global threat, drug makers large and small have scrambled to advance their best ideas for thwarting a pandemic. The crisis has catalyzed the development of novel vaccines across
-
As the world and biopharma grapple with developing vaccines and drugs against COVID-19, researchers are turning to a handful of drugs that show particular promise. Several of those drugs are by companies with offices or headquarters in the San Francisco Bay Area. Here’s a look.
-
Epidemiologists believe COVID-19 will likely affect millions of people in the U.S. If early prevention efforts are not made Swine Flu Pandemic of 2009.
-
Biotech Companies Concentrate on Vaccine Formulation and Distribution
3/19/2020
COVID-19 has drastically changed the world's social and economic landscape since the virus was first identified in China in January.
-
As the number of diagnosed cases of COVID-19 continue to increase across the globe and more and more governments are urging citizens to self-quarantine, the pharmaceutical and life sciences industry continues to work toward the development of a vaccine and therapies for the respiratory infection ...